39310 TRABECTEDIN PHASE II CLINICAL TRIALS: POOLED ANALYSIS OF SAFETY .A Cioffi ; A LeCesne; J Blay; S Delaloge; A Yovine; R Maki; A Nieto; J Jiao; G Demetri .
*******************************************
39453 COMPASSIONATE USE ADMINISTRATION OF TRABECTEDIN IN A 24- HOUR INFUSION EVERY 3 WEEKS (Q3W) IN PRETREATED ADVANCED SARCOMA PATIENTS .A Yovine; I Robert Judson; J Blay; P Giovanni Casali; J Misset; B Louis Samuels; C Lebedinsky; J Fernando Perez; P Zintl; P Schoffski .